春立医疗
(688236)
| 流通市值：36.54亿 | | | 总市值：48.60亿 |
| 流通股本：2.88亿 | | | 总股本：3.84亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 626,477,112.4 | 417,104,217.14 | 216,972,373.23 | 1,045,766,405.34 |
| 营业总成本 | 419,617,724.72 | 286,007,552.15 | 152,107,504.3 | 722,853,785.21 |
| 其他经营收益 | | | | |
| 营业利润 | 214,163,811.68 | 135,089,659.77 | 68,048,737.03 | 302,245,079.93 |
| 利润总额 | 212,486,833.21 | 133,457,244.13 | 68,014,570.8 | 301,711,713.59 |
| 净利润 | 188,583,836.44 | 119,938,952.22 | 61,681,083.77 | 272,625,119.37 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 188,583,836.44 | 119,938,952.22 | 61,681,083.77 | 272,625,119.37 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 3,007,211,044.79 | 2,944,782,294.82 | 2,976,486,615.19 | 3,011,500,050.4 |
| 非流动资产: | | | | |
| 非流动资产合计 | 641,420,554.86 | 646,577,686.8 | 655,281,404.74 | 649,634,810.73 |
| 资产总计 | 3,648,631,599.65 | 3,591,359,981.62 | 3,631,768,019.93 | 3,661,134,861.13 |
| 流动负债: | | | | |
| 流动负债合计 | 439,279,589.44 | 449,872,275.76 | 488,914,115.34 | 578,602,954.95 |
| 非流动负债: | | | | |
| 非流动负债合计 | 91,104,459.67 | 91,885,039.54 | 94,180,359.37 | 95,539,444.73 |
| 负债合计 | 530,384,049.11 | 541,757,315.3 | 583,094,474.71 | 674,142,399.68 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,116,696,614.79 | 3,048,096,106.86 | 3,047,178,827.01 | 2,985,467,836.15 |
| 股东权益合计 | 3,118,247,550.54 | 3,049,602,666.32 | 3,048,673,545.22 | 2,986,992,461.45 |
| 负债和股东权益合计 | 3,648,631,599.65 | 3,591,359,981.62 | 3,631,768,019.93 | 3,661,134,861.13 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 611,037,345.42 | 393,467,990.41 | 147,928,203.2 | 1,217,975,283.51 |
| 经营活动现金流出小计 | 493,522,932.87 | 359,145,976.69 | 158,856,257.63 | 813,135,358.43 |
| 经营活动产生的现金流量净额 | 117,514,412.55 | 34,322,013.72 | -10,928,054.43 | 404,839,925.08 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 797,735,931.51 | 797,651,769.51 | - | 1,704,632,166.86 |
| 投资活动现金流出小计 | 756,522,559.67 | 752,561,388.98 | 19,994,053.2 | 1,816,327,974.35 |
| 投资活动产生的现金流量净额 | 41,213,371.84 | 45,090,380.53 | -19,994,053.2 | -111,695,807.49 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 142,701,936 | 106,950,973.75 | 81,409,241.95 | 29,514,440.23 |
| 筹资活动产生的现金流量净额 | -142,701,936 | -106,950,973.75 | -81,409,241.95 | -29,514,440.23 |
| 汇率变动对现金及现金等价物的影响 | -563,101.66 | -537,020.27 | -320,760.32 | -174,841.04 |
| 现金及现金等价物净增加额 | 15,462,746.73 | -28,075,599.77 | -112,652,109.9 | 263,454,836.32 |
| 期末现金及现金等价物余额 | 1,417,935,233.71 | 1,374,396,887.21 | 1,289,820,377.08 | 1,402,472,486.98 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -28,075,599.77 | - | 263,454,836.32 |
最新报告期：2026-09-30| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华创证券 | 郑辰,李婵娟,陈俊威 | 0.76 | 0.93 | 1.13 | 2026-09-30 |
| 中信建投 | 刘慧彬,李虹达,王在存,贺菊颖 | 0.74 | 0.85 | 0.99 | 2026-09-29 |
| 华泰证券 | 代雯,孔垂岩,王殷杰 | 0.76 | 0.95 | 1.13 | 2026-08-31 |